Share This Page
Drug Price Trends for MOEXIPRIL HCL
✉ Email this page to a colleague

Average Pharmacy Cost for MOEXIPRIL HCL
Drug Name | NDC | Price/Unit ($) | Unit | Date |
---|---|---|---|---|
MOEXIPRIL HCL 15 MG TABLET | 00093-5150-01 | 0.91824 | EACH | 2025-01-22 |
MOEXIPRIL HCL 7.5 MG TABLET | 00093-0017-01 | 0.90311 | EACH | 2025-01-22 |
MOEXIPRIL HCL 15 MG TABLET | 68462-0208-01 | 0.91824 | EACH | 2025-01-22 |
MOEXIPRIL HCL 7.5 MG TABLET | 68462-0209-01 | 0.90311 | EACH | 2025-01-22 |
MOEXIPRIL HCL 15 MG TABLET | 00093-5150-01 | 0.88441 | EACH | 2024-12-18 |
MOEXIPRIL HCL 7.5 MG TABLET | 68462-0209-01 | 0.92984 | EACH | 2024-12-18 |
MOEXIPRIL HCL 15 MG TABLET | 68462-0208-01 | 0.88441 | EACH | 2024-12-18 |
>Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Moexipril HCL
Introduction to Moexipril HCL
Moexipril HCL, an angiotensin-converting enzyme (ACE) inhibitor, is used primarily in the treatment of hypertension. It is available as a generic medication and also under the brand name Univasc. Here, we will delve into the market analysis and price projections for Moexipril HCL.
Market Size and Growth
The global Moexipril market has shown steady growth in recent years. As of 2023, the market was valued at US$ 102 million and is anticipated to reach US$ 128.9 million by 2030, witnessing a Compound Annual Growth Rate (CAGR) of a significant percentage[3].
Market Competition
The Moexipril HCL market is characterized by competition among various pharmaceutical companies. The generic version of Moexipril HCL, produced by companies like Glenmark Pharmaceuticals, competes with the brand version, Univasc. The market competition is further influenced by the presence of other ACE inhibitors and Angiotensin II Receptor Blockers (ARBs)[2].
Pricing and Cost Savings
The pricing of Moexipril HCL varies significantly depending on the source and any available discounts. Here are some key price points:
- Retail Price: The typical cash price for Moexipril HCL can range from $48.19 to $94.19 per 30 tablets of 15mg each, depending on the pharmacy[1][2].
- Discounted Prices: Using coupons or discount cards, such as those from SingleCare or GoodRx, can reduce the cost dramatically. For example, with a SingleCare card, the price can be as low as $15.44 for 30 tablets of 15mg each[1][2].
Market Dynamics
Supply and Demand
The demand for Moexipril HCL is driven by the prevalence of hypertension and the need for effective antihypertensive medications. The supply side is influenced by the production capacity of pharmaceutical companies and the regulatory environment. The global supply and consumption of Moexipril HCL are expected to grow, driven by increasing healthcare needs and expanding market reach[4].
Economic Impact
The macroeconomic environment plays a crucial role in the Moexipril HCL market. Economic stability and healthcare policies can affect the affordability and accessibility of the medication. For instance, changes in healthcare policies or economic downturns can impact the market size and growth rate[4].
Price Projections
Short-Term Projections
In the short term, prices for Moexipril HCL are expected to remain relatively stable, with minor fluctuations based on market competition and discount programs. The use of coupons and discount cards will continue to offer significant cost savings for patients.
Long-Term Projections
Long-term price projections indicate a potential decrease in prices due to increased competition from generic versions and other antihypertensive medications. The market is expected to grow, but the prices may stabilize or decrease slightly as more generic options become available and the market becomes more saturated[3].
Regional Market Analysis
Global Market
The global Moexipril HCL market is diverse, with different regions having varying levels of demand and supply. The market share and production capacity vary significantly across countries such as the USA, EU, Japan, and China. The Chinese market, in particular, is expected to play a significant role in the global supply and consumption of Moexipril HCL[4].
Key Markets
- USA: The US market is one of the largest for Moexipril HCL, driven by a high prevalence of hypertension and a well-established healthcare system.
- EU: The European market also shows significant demand, with a focus on both branded and generic versions of the medication.
- China: China is emerging as a major player in the production and consumption of Moexipril HCL, driven by its large population and growing healthcare needs[4].
Industry Challenges and Opportunities
Challenges
- Regulatory Hurdles: Changes in regulatory policies can impact the approval and distribution of Moexipril HCL.
- Market Saturation: The increasing availability of generic versions and other antihypertensive medications can lead to market saturation and reduced prices.
- Economic Factors: Economic instability can affect the affordability and accessibility of the medication[4].
Opportunities
- Growing Demand: The increasing prevalence of hypertension globally presents a growing demand for effective antihypertensive medications like Moexipril HCL.
- Expansion into New Markets: There is an opportunity for pharmaceutical companies to expand their market reach into emerging economies.
- Innovative Delivery Systems: Developing innovative delivery systems or combination therapies can enhance the market position of Moexipril HCL[4].
Key Takeaways
- Market Growth: The global Moexipril HCL market is expected to grow, reaching US$ 128.9 million by 2030.
- Pricing: Prices can be significantly reduced using discount programs and coupons.
- Market Dynamics: The market is influenced by supply and demand, economic factors, and regulatory policies.
- Regional Analysis: The US, EU, and China are key markets for Moexipril HCL.
- Challenges and Opportunities: The industry faces challenges such as regulatory hurdles and market saturation but also has opportunities for growth and innovation.
FAQs
What is Moexipril HCL used for?
Moexipril HCL is used primarily in the treatment of hypertension. It is an angiotensin-converting enzyme (ACE) inhibitor that helps lower blood pressure[2].
How much does Moexipril HCL cost?
The cost of Moexipril HCL can vary, but the typical cash price is around $48.19 to $94.19 per 30 tablets of 15mg each. However, using discount programs can reduce the cost to as low as $15.44[1][2].
Is Moexipril HCL available as a generic medication?
Yes, Moexipril HCL is available as a generic medication, which is significantly cheaper than the brand version, Univasc[1].
What are the potential side effects of Moexipril HCL?
Common side effects include cough, dizziness, and increased potassium levels. It is important to consult a healthcare provider for a full list of potential side effects[5].
Can Moexipril HCL be used in combination with other medications?
Yes, Moexipril HCL can be used in combination with other medications, such as the diuretic hydrochlorothiazide (as moexipril/hctz), to enhance its antihypertensive effects[2].
Sources
- SingleCare: Moexipril Hcl Coupons & Prices.
- GoodRx: Moexipril Prices, Coupons & Savings Tips.
- MarketResearchReports.com: Global Moexipril Market Research Report 2024.
- Prof-Research.com: Moexipril Hydrochloride Market Size, Share, Trend and Forecast to 2029.
- R&D Systems: Moexipril hydrochloride (CAS 82586-52-5).
More… ↓